# Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability

> **NCT06134401** · NA · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 40 (estimated)

## Conditions studied

- Neuromuscular Diseases
- Neurodevelopmental Disorders
- Cerebral Palsy

## Interventions

- **DEVICE:** saline

## Key facts

- **NCT ID:** NCT06134401
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06134401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06134401, "Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06134401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*